A. Raub, S. H. Isa, N. M. Zailani, and H. A. , Distribution of HPV Genotypes in Cervical Cancer in Multi-ethnic Malaysia, Asian Pac J Cancer Prev, vol.12, pp.645-653, 2014.

M. Ben-abdallah, S. Zehani, H. Ben-ayoub, and W. , Registre des Cancers Nord-Tunisie, 2009.

L. Benerini-gatta, M. Cadei, and P. Balzarini, Switzerland pp 107 Numbers 160 IARC Scientific Publications Carvalho Nde O, the Narratives and the Maps, vol.56, pp.73-81, 2007.

H. Kitchener, K. Canfell, and C. Gilham, The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds, Health Technol Assess, vol.18, pp.1-196, 2014.

N. Chaouki, F. X. Bosch, and N. Muñoz, The viral origin of cervical cancer in Rabat, Morocco, Int J Cancer, vol.75, pp.546-54, 1998.

G. M. Clifford, J. S. Smith, M. Plummer, N. Munoz, and S. Francheschi, Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis, British Journal of Cancer, vol.88, pp.63-73, 2003.

G. Clifford, S. Franceschi, M. Diaz, N. Munoz, and L. L. Villa, Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases, Vaccine, vol.31, pp.26-34, 2006.

V. Cogliano, R. Baan, and K. Straif, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses, Lancet Oncol, vol.6, p.204, 2005.

A. M. De-roda-husman, J. M. Walboomers, A. J. Van-den-brule, C. J. Meijer, and P. J. Snijders, The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR, J Gen Virol, vol.76, pp.1057-62, 1995.

S. De-sanjose and W. G. Quint, Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide, Lancet Oncol, vol.11, pp.1048-56, 2010.

C. Eklund, T. Zhou, and J. Dillner, Global proficiency study of human papillomavirus genotyping, WHO Human Papillomavirus Laboratory Network, vol.48, pp.4147-55, 2010.

P. Fattorini, G. Marrubini, and U. Ricci, Estimating the integrity of aged DNA samples by CE Electrophoresis, vol.30, pp.3986-95, 2009.

J. Ferlay, H. R. Shin, and F. Bray, Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, vol.127, pp.2893-917, 2008.

D. Hammouda, N. Muñoz, and R. Herrero, Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors, Int J Cancer, vol.113, pp.483-492, 2005.

D. M. Harper, E. L. Franco, and C. M. Wheeler, Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial, Lancet, vol.367, pp.1247-55, 2006.

M. Hsairi, R. Fakfakh, R. Bellaaj, and N. Achour, Attitude to cervical cancer screening of women residing in two regions of northern Tunisia, Tunis Med, vol.81, pp.721-751, 2003.

, Wkly Epidemiol Rec, vol.84, pp.118-149

K. Krennhrubec, K. Mrad, and B. Sriha, HPV types and variants among cervical cancer tumors in three regions of Tunisia, J Med Virol, vol.83, pp.651-658, 2011.

S. S. Kulkarni, S. S. Kulkarni, and P. Vastrad, Prevalence and distribution of high risk human papillomavirus. (HPV) Types 16 and 18 in carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in karnataka, India. Asian Pac J Cancer Prev, vol.12, pp.645-653, 2011.

B. G. Lazzar, S. Hajjem, H. Aounallah-skhiri, N. Achour, and M. Hsairi, Mortality from cancer in Tunisia: calculating years of life lost, Sante Publique, vol.23, pp.31-40, 2011.

S. H. Lee, Guidelines for the use of molecular tests for the detection and genotyping of human papilloma virus from clinical specimens, Methods Mol Biol, vol.903, pp.65-101, 2012.

M. Longy, B. Duboue, P. Soubeyran, and D. Moynet, Method for the purification of tissue DNA suitable for PCR after fixation with Bouin's fluid. Uses and limitations in microsatellite typing, Diagn Mol Pathol, vol.6, pp.167-73, 1997.

M. Sherry, E. A. , M. Goldrick, A. Kay, and E. W. , Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles, Clin Gen, vol.72, pp.441-448, 2007.

N. Missaoui, S. Hmissa, and A. Trabelsi, Prevalence of HPV infection in precancerous and cancerous lesions of the uterine cervix in Tunisia, Ann Biol Clin, vol.68, pp.297-303, 2010.

N. Muñoz, F. X. Bosch, and X. Castellsagué, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, vol.111, pp.278-85, 2004.

M. Njah, B. Ahmed, S. Marzouki, and M. , Cancer of the breast and uterine cervix: knowledge level and preventive practices in a segment of the Tunisian population, Sante, vol.4, pp.299-302, 1994.

J. Paavonen, P. Naud, and J. Salmeron, Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women, Lancet, vol.374, pp.301-315, 2009.

X. H. Shen and S. H. Liu, Human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in hangzhou, China. Asian Pacific J Cancer Prev, vol.14, pp.3603-3609, 2013.

K. D. Sjoeborg, A. Tropé, and A. K. Lie, HPV genotype distribution according to severity of cervical neoplasia, Gynecol Oncol, vol.118, pp.29-34, 2010.

L. L. Villa, R. L. Costa, and C. A. Petta, High sustained efficacy of a prophylactic quadrivalent human papillomavirus type 6:11:16:18 L1 virus like particle vaccine through 5 years of follow up, Br J Cancer, vol.95, pp.1459-66, 2006.

J. M. Walboomers, M. V. Jacobs, and M. M. Manos, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Patho, vol.189, pp.12-21, 1999.

C. Webersinke, S. Doppler, F. Roithmeier, W. Stummvoll, and R. J. Silye, Cervical biopsies and cytological smears -A comparison of sample materials in HPV diagnostics, Clin Virol, vol.56, pp.69-71, 2013.

E. R. Dillner, J. Zhou, T. Geneva, and . Switzerland, Human papillomavirus laboratory manual, World Health Organization, 2009.